Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Authors

Showing 2 results for author "Mary Lisha Paul".

Back to authors

Thumbnail for A Phase 2 Open-Label Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's-Choice Thrombopoietin Receptor Agonist in Patients With Primary Immune Thrombocytopenia: VAY2EXPLORE Study Design

MDS - 1074

A Phase 2 Open-Label Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's-Choice Thrombopoietin Receptor Agonist in Patients With Primary Immune Thrombocytopenia: VAY2EXPLORE Study Design

Mary Lisha Paul

Poster Presenter: Mary Lisha Paul

Thumbnail for Effect of Ianalumab Plus Eltrombopag on Patient-Reported Outcomes in Primary Immune Thrombocytopenia: Results from the VAYHIT2 Phase 3 Trial

MDS - 435

Effect of Ianalumab Plus Eltrombopag on Patient-Reported Outcomes in Primary Immune Thrombocytopenia: Results from the VAYHIT2 Phase 3 Trial

Mary Lisha Paul

Poster Presenter: Mary Lisha Paul

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors